Contrast-Enhanced Ultrasonography with Arrival Time Parametric Imaging as a Non-Invasive Diagnostic Tool for Liver Cirrhosis.
Raluca LupușoruIoan SporeaIulia RatiuDiana LungeanuAlina PopescuMirela DănilăRuxandra MareLuciana MarcAndrada LascăuTudor Voicu MogaFelix BendeAna-Maria GhiuchiciRoxana Lucia SirliPublished in: Diagnostics (Basel, Switzerland) (2022)
Liver biopsy is the gold standard method for staging liver fibrosis, but it is an invasive procedure that is associated with some complications. There are also non-invasive techniques for assessing liver fibrosis, such as elastography and biological tests, but these techniques can fail in detection or generate false measurements depending on the subject's condition. This study aimed to determine whether liver fibrosis can be evaluated using contrast-enhanced ultrasonography with arrival time parametric imaging using the ultrasound machine's parametric image software, the method being called (CEUS-PAT). CEUS-PAT was performed on each subject using SonoVue as a contrast agent, and images showing liver parenchyma and the right kidney on a single screen were used for analysis in parametric imaging, which was performed using the proprietary software of the ultrasound system. The ratio between the kidney and liver arrival times was calculated. The study included 64 predominantly male (56.3%) subjects, 37 cirrhotic patients, and 27 healthy volunteers, with a mean age of 58.98 ± 8.90 years. Significant differences were found between the liver cirrhosis and healthy groups regarding CEUS-PAT, 0.83 ± 0.09 vs. 0.49 ± 0.11, p < 0.0001. The correlation between CEUS-PAT and VCTE was r = 0.81. The optimal cut-off value for detecting liver cirrhosis was >0.7, with an AUC of 0.98, p < 0.001, Se = 89.19%, Sp = 100%, PPV = 100%, and NPV = 87.1%. We demonstrate that CEUS-PAT achieves excellent performance in diagnosing liver cirrhosis and is a fast method for diagnosing liver cirrhosis that can even be applied in situations where the use of other methods is excluded.
Keyphrases
- liver fibrosis
- contrast enhanced
- contrast enhanced ultrasound
- magnetic resonance imaging
- diffusion weighted
- magnetic resonance
- computed tomography
- high resolution
- diffusion weighted imaging
- deep learning
- newly diagnosed
- high throughput
- ultrasound guided
- dual energy
- risk factors
- lymph node
- data analysis
- mass spectrometry
- fluorescence imaging
- patient reported outcomes
- label free
- patient reported